Melanoma and Skin Cancer Research Group

Professor Fernandez-Peñas and his team pioneer non-invasive methods for early skin cancer diagnosis, aiming to replace biopsies. They explore non-invasive technologies to analyse skin surface proteins, potentially revolutionizing the diagnosis of various skin conditions, including melanoma and non-melanoma skin cancers. In NSW, their team leads a project deploying a network of 3D photography systems across Australia, aiming to enhance melanoma diagnosis through Artificial Intelligence. Simultaneously, they collaborate with researcher from the University of Sydney and the Nano Institute, utilizing quantum technology to develop new molecules for skin cancer treatment and improved/enhanced sunscreens, as well as addressing a challenge in drug development posed by the limitations of conventional computers in predicting quantum chemical dynamics

Recent Achievements

Prof Pablo Fernandez-Penas together with other researchers from the University of Sydney received $1.5 million in grant funding through Wellcome Leap Quantum for Bio program to accelerate applications of quantum computing in skin and demonstrate quantum-enabled solutions to address skin health challenges..
Dr Rachel TEH successfully completed her PhD: Dr Teh joined the Melanoma and Skin Cancer Group in 2019 as a PhD student to work on proteomic studies of early melanoma lesions. During her studies, she processed hundreds of samples of early melanoma lesions using proteomic technology and identified protein biomarkers that could assist with the early diagnosis of the lesions.
Dr Azimi was invited to deliver a Keynote Speech at the High School Cancer Symposium held by Young Australian Cancer Initiative at the Westmead Institute for Medical Research on in Nov 2023. He delivered a talk on melanoma biology and how healthy melanocytes may turn nasty and become cancerous.